Stem cell eye therapy: 5-Year safety watch begins
NCT ID NCT03167203
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study follows people who received a stem cell treatment for macular degeneration to see if any late side effects appear more than 5 years later. Participants fill out a yearly questionnaire about eye problems, infections, immune disorders, cancer, or other health changes. The goal is to understand the long-term safety of this experimental therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATIVE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Private Practice
Kansas City, Missouri, 64133, United States
-
Site GB44001
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.